Torsten Zimmermann

662 total citations
24 papers, 535 citations indexed

About

Torsten Zimmermann is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pharmacology. According to data from OpenAlex, Torsten Zimmermann has authored 24 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Torsten Zimmermann's work include Medical Imaging Techniques and Applications (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Retinal Diseases and Treatments (3 papers). Torsten Zimmermann is often cited by papers focused on Medical Imaging Techniques and Applications (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Retinal Diseases and Treatments (3 papers). Torsten Zimmermann collaborates with scholars based in Germany, United States and Switzerland. Torsten Zimmermann's co-authors include H Laufen, Klaus‐Dieter Riedel, A Wildfeuer, Beate Rohde, Andrea Thiele, Balázs Gulyás, Anja Hoffmann, Akihiro Takano, Andrea Varrone and Christer Halldin and has published in prestigious journals such as The American Journal of Cardiology, Journal of the American Academy of Dermatology and European Journal of Pharmacology.

In The Last Decade

Torsten Zimmermann

24 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torsten Zimmermann Germany 14 132 128 112 79 62 24 535
Guohua Deng China 12 86 0.7× 144 1.1× 70 0.6× 12 0.2× 70 1.1× 29 688
Paola Leone Spain 14 100 0.8× 246 1.9× 25 0.2× 93 1.2× 32 0.5× 22 780
M. Joseph John India 11 39 0.3× 100 0.8× 95 0.8× 17 0.2× 21 0.3× 61 522
Guo-Tong Xu China 16 62 0.5× 280 2.2× 120 1.1× 59 0.7× 12 0.2× 19 762
Yongjie Qin China 15 32 0.2× 160 1.3× 71 0.6× 32 0.4× 11 0.2× 46 612
Katarzyna A. Lisowska Poland 15 52 0.4× 83 0.6× 19 0.2× 28 0.4× 49 0.8× 46 626
Valquíria Bueno Brazil 15 56 0.4× 233 1.8× 12 0.1× 52 0.7× 27 0.4× 51 655
Miho Murakami Japan 14 68 0.5× 116 0.9× 32 0.3× 20 0.3× 31 0.5× 43 680
S. Martha Meyer United States 12 55 0.4× 87 0.7× 97 0.9× 20 0.3× 34 0.5× 21 623
Joanna J. Chmielinska United States 15 48 0.4× 88 0.7× 79 0.7× 7 0.1× 15 0.2× 32 561

Countries citing papers authored by Torsten Zimmermann

Since Specialization
Citations

This map shows the geographic impact of Torsten Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Zimmermann more than expected).

Fields of papers citing papers by Torsten Zimmermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Zimmermann. The network helps show where Torsten Zimmermann may publish in the future.

Co-authorship network of co-authors of Torsten Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Zimmermann. A scholar is included among the top collaborators of Torsten Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Zimmermann. Torsten Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zimmermann, Torsten, et al.. (2020). The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial. British Journal of Clinical Pharmacology. 87(3). 925–936. 3 indexed citations
3.
Kaiser, Peter K., Laurent Kodjikian, Jean‐François Korobelnik, et al.. (2019). Systemic pharmacokinetic/pharmacodynamic analysis of intravitreal aflibercept injection in patients with retinal diseases. BMJ Open Ophthalmology. 4(1). e000185–e000185. 13 indexed citations
4.
Joussen, Antonia M., Sebastián Wolf, Peter K. Kaiser, et al.. (2018). The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial. British Journal of Clinical Pharmacology. 85(2). 347–355. 41 indexed citations
5.
Höchel, Joachim, Olaf Prien, Torsten Zimmermann, et al.. (2018). Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential. Clinical Pharmacokinetics. 57(8). 1001–1015. 25 indexed citations
6.
Zimmermann, Torsten, Joachim Höchel, Michael Becka, et al.. (2018). Topical administration of regorafenib eye drops: phase I dose‐escalation study in healthy volunteers. British Journal of Clinical Pharmacology. 84(5). 865–875. 8 indexed citations
7.
Varrone, Andrea, Anton Forsberg, Akihiro Takano, et al.. (2013). In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40(6). 921–931. 64 indexed citations
8.
Takano, Akihiro, Fredrik Piehl, Jan Hillert, et al.. (2013). In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106. EJNMMI Research. 3(1). 30–30. 63 indexed citations
9.
10.
11.
Barthel, Henryk, Julia Luthardt, Georg Becker, et al.. (2011). Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. 38(9). 1702–1714. 84 indexed citations
12.
Takano, Akihiro, Balázs Gulyás, Andrea Varrone, et al.. (2011). Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study. European Journal of Nuclear Medicine and Molecular Imaging. 38(11). 2058–2065. 27 indexed citations
13.
Barthel, Henryk, Michio Senda, Julia Luthardt, et al.. (2010). P2‐402: Influence of ethnic group, age, gender, and tracer mass dose on florbetaben β‐amyloid brain PET results in elderly normal controls. Alzheimer s & Dementia. 6(4S_Part_14). 3 indexed citations
14.
Baumann, Ulrich, Malcolm King, Ernst M. App, et al.. (2004). Long‐Term Azithromycin Therapy in Cystic Fibrosis Patients: A Study on Drug Levels and Sputum Properties. Canadian Respiratory Journal. 11(2). 151–155. 42 indexed citations
15.
Zimmermann, Torsten, et al.. (2004). Safety of large area application of a novel vitamin D analogue (Tisocalcitate ointment) in healthy volunteers. Journal of the American Academy of Dermatology. 50(3). P154–P154. 1 indexed citations
16.
Schneider, Christian, Holger Diedrichs, Klaus‐Dieter Riedel, Torsten Zimmermann, & H. W. Höpp. (2000). In vivo uptake of azithromycin in human coronary plaques. The American Journal of Cardiology. 86(7). 789–791. 11 indexed citations
17.
Zimmermann, Torsten, et al.. (1999). The Pharmacokinetics of Extended‐Release Formulations of Calcium Antagonists and of Amlodipine in Subjects with Different Gastrointestinal Transit Times. The Journal of Clinical Pharmacology. 39(10). 1021–1031. 25 indexed citations
18.
Laufen, H, et al.. (1998). Accumulation of Fluconazole in Scalp Hair. The Journal of Clinical Pharmacology. 38(2). 138–143. 13 indexed citations
19.
Riedel, Klaus‐Dieter, A Wildfeuer, H Laufen, & Torsten Zimmermann. (1992). Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples. Journal of Chromatography B Biomedical Sciences and Applications. 576(2). 358–362. 36 indexed citations
20.
Zimmermann, Torsten, et al.. (1991). Comparison of isobutyl nitrate and isobutyl nitrite: tolerance and cross-tolerance to glyceryl trinitrate. European Journal of Pharmacology. 192(1). 181–184. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guohua Deng Breakdown of academic impact, for papers by Paola Leone Breakdown of academic impact, for papers by M. Joseph John Breakdown of academic impact, for papers by Guo-Tong Xu Breakdown of academic impact, for papers by Yongjie Qin Breakdown of academic impact, for papers by Katarzyna A. Lisowska Breakdown of academic impact, for papers by Valquíria Bueno Breakdown of academic impact, for papers by Miho Murakami Breakdown of academic impact, for papers by S. Martha Meyer Breakdown of academic impact, for papers by Joanna J. Chmielinska
Rankless by CCL
2026